NewAmsterdam Pharma NAMS
NASDAQ NAMS
$24.16 -0.16 (-0.66%)
At close: Oct 1, 2026 · 4:00 PM EDT

NewAmsterdam Pharma (NAMS) Other Non-Current Assets (2022 - 2026)

Updated

NewAmsterdam Pharma (NAMS) posted Other Non-Current Assets of $2.59 million for Q1 2026.

Analysis

NewAmsterdam Pharma (NAMS) Other Non-Current Assets (2022 - 2026) Analysis & Trends

At the end of FY2023, NewAmsterdam Pharma's Other Non-Current Assets came in at $35,000, down 77.6% from FY2022.

  • In prior years, NewAmsterdam Pharma's Other Non-Current Assets was $156,000 in FY2022.
  • The Q1 2026 figure stands as the lowest quarterly Other Non-Current Assets since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 NewAmsterdam Pharma 2.86 Bn 2.86 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 2.59 Mn
Jun 30, 2024 8,000.00
Mar 31, 2024 16,000.00
Dec 31, 2023 35,000.00
Jun 30, 2023 101,269.97
Dec 31, 2022 148,956.12
API Access

NewAmsterdam Pharma Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=NAMS&period=max&api_key=YOUR_API_KEY